| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $43.9M | +118.3% |
| R&D Expense | $68.5M | -20.7% |
| SG&A Expense | $20.2M | +8.5% |
| Operating Income | -$51.5M | +47.3% |
| Pre-tax Income | -$43.6M | +46.3% |
| Income Tax | -$106K | -128.8% |
| Net Income | -$43.5M | +46.7% |
| EPS (Basic) | -$3.47 | -303.5% |
| EPS (Diluted) | -$3.47 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.7M | -66.1% |
| Accounts Receivable | $290K | -43.2% |
| Current Assets | $80.7M | -45.2% |
| Total Assets | $82.5M | -48.8% |
| Current Liabilities | $24.7M | -41.3% |
| Total Liabilities | $31.3M | -56.2% |
| Stockholders' Equity | $51.2M | -43.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.0M | -33.8% |
| Capital Expenditures | $194K | -95.3% |
| Investing Cash Flow | -$194K | +95.3% |
| Financing Cash Flow | -$1.3M | -101.9% |
| Free Cash Flow | -$77.2M | -25.1% |
| -303.5% |